Clinical Trial Update: Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma

View source ↗

Summary

The clinical trial investigating ultraviolet light exposure and immunosuppression in cutaneous melanoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Melanoma | Status: TERMINATED